March 28, 1996
UroHealth Systems Inc. said it agreed to buy several product lines that together accounted for $4.6 million in revenue last year. The maker of urological products said it plans to acquire suction and surgical products from Ximed Medical Systems, a privately held San Jose manufacturer. The products generated $3 million in revenue last year. UroHealth also expects to buy endoscopic products that accounted for revenue of $1.
December 20, 1994 |
Davstar Industries Ltd. said Monday that it will buy a Minneapolis-based medical-products company in a transaction valued at $12.4 million. Dacomed Corp., a privately held company that makes urological products, had revenue of about $9 million for its latest fiscal year. Davstar, which designs and manufactures disposable medical products for hospitals, nursing homes and home health care, has annual revenue of about $4.5 million. Michael A.
March 14, 1997
Urohealth Systems Inc. said Thursday it has signed a five-year contract to supply its medical and surgical products to a major hospital group. The contract to supply Premier Inc.'s 1,800 hospitals and other health care facilities lists purchasing "targets" of more than $1 billion over the five-year term, although no minimum purchasing requirements are included.
August 5, 1994
* Patrick J. Fortune has been appointed president and chief operating officer of Coram Healthcare Corp. in Newport Beach, effective Aug. 15. He most recently served as corporate vice president of information management for Bristol-Meyers Squibb Co. Coram, which has announced plans to relocate its headquarters to Boulder, Colo., was formed as a result of the four-way merger last month of United T2 Medical, Curaflex Health Services, Medisys Inc. and HealthInfusion Inc.
September 14, 1995 |
Urohealth Systems Inc., which has been on an acquisition spree, is beefing up its management team. Officials of the Costa Mesa maker of urological products said Wednesday that Julian Osbon, the chairman and chief executive of Osbon Medical Systems, will become Urohealth's president and chief operating officer and a director when Urohealth's recently announced purchase of Atlanta-based Osbon is completed.